BITROBIUS GENETICS LTD
Company number 13040147 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
£1,549,576
Balance sheet as at 2025-11-30
Overview
- Company type
- Private Limited Company
- Incorporated
- 2020-11-24
- Employees
- 5 (2025 accounts · was 6 in 2024)
- Registered office
- Alderley Park Congleton Road, Nether Alderley, Macclesfield, Cheshire, England, SK10 4TG
- Postcode
- SK10 4TG
- Capital
- 227 GBP
- Accounts category
- Total Exemption Full
Accounts
- Last made up to
- 2025-11-30
- Next due by
- 2027-08-31
- Financial year end
- 30 November
Confirmation statement
- Last statement dated
- 2025-11-23
- Next due by
- 2026-12-07
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 3 current
Contact details
- Website
- bitrobius.com
Bitrobius Genetics is developing Gentrafix™, a groundbreaking technology that delivers DNA to every affected cell, which can be used to treat genetic diseases.
Among its peers
Top 25%
by shareholders' funds, of 44 similar companies in SK
Trading since 2020.
No.5 of the largest research and experimental development on biotechnology companies in Stockport →
Competitors Stockport
-
4. CROBIO LTD
This company ranks 5 among research and experimental development on biotechnology in Stockport.
The class of 2020
41%
of the 595 companies in this sector incorporated in 2020 are still active today; 55% have since been dissolved.
A fact about the year, not a forecast for this company.